Citation Impact
Citing Papers
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis
2015
Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin
2007
Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe
2018 StandoutNobel
Antibiotics: past, present and future
2019 Standout
Paper-based microfluidic point-of-care diagnostic devices
2013 Standout
A view on drug resistance in cancer
2019 StandoutNature
Identification of new components of the RipC-FtsEX cell separation pathway of Corynebacterineae
2019 StandoutNobel
Immunological biomarkers of tuberculosis
2011
Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis
2016
Development of vaccines and antivirals for combating viral pandemics
2020 StandoutNobel
Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion
2012 StandoutNobel
Tuberculosis
2011
Studies on molecular properties prediction, antitubercular and antimicrobial activities of novel quinoline based pyrimidine motifs
2014
Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy
2009
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
2009 Standout
Commercialization of microfluidic point-of-care diagnostic devices
2012
Tuberculosis
2015
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
2010
Synthesis, antimicrobial, antimycobacterial and structure–activity relationship of substituted pyrazolo-, isoxazolo-, pyrimido- and mercaptopyrimidocyclohepta[b]indoles
2011
Peptide deformylase – a promising therapeutic target for tuberculosis and antibacterial drug discovery
2009
Converting Cancer Therapies into Cures: Lessons from Infectious Diseases
2012
Crohn's disease
2012 Standout
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
2010
Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles
2010
A low cost point-of-care viscous sample preparation device for molecular diagnosis in the developing world; an example of microfluidic origami
2011
The REDCap consortium: Building an international community of software platform partners
2019 Standout
The Global Fight Against Tuberculosis
2018
Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania
2015
Structural insights into quinolone antibiotic resistance mediated by pentapeptide repeat proteins: conserved surface loops direct the activity of a Qnr protein from a Gram-negative bacterium
2011
TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy
2019 Standout
The challenge of new drug discovery for tuberculosis
2011 Nature
In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide
2010
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
2014
Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy
2012
Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia
2015
Antibiotics in the clinical pipeline in 2011
2011
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
Designing antimicrobial peptides: form follows function
2011 Standout
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections
2010
Treatment of latent infection withMycobacterium tuberculosis: update 2010
2010
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?
2016
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Newer antibacterial drugs for a new century
2010
The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
2020
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
2011
Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology
2012
Tuberculosis
2007
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future
2010 Standout
Host-directed therapies for bacterial and viral infections
2017
Advances in the development of new tuberculosis drugs and treatment regimens
2013
Regulation of type I interferon responses
2013 Standout
Cyclopropane Modification of Trehalose Dimycolate Drives Granuloma Angiogenesis and Mycobacterial Growth through Vegf Signaling
2018 StandoutNobel
An RNA-centric dissection of host complexes controlling flavivirus infection
2019 StandoutNobel
InhibitingMycobacterium tuberculosiswithin and without
2016
Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation
2020 StandoutNobel
Transmission and Institutional Infection Control of Tuberculosis
2015
Prospects for new antibiotics: a molecule-centered perspective
2013
Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe
2012
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Mechanism of Quinolone Action and Resistance
2014 Standout
Global tuberculosis drug development pipeline: the need and the reality
2010
The antimicrobial activity of nanoparticles: present situation and prospects for the future
2017 Standout
Biomarkers for tuberculosis disease activity, cure, and relapse
2009
Silicosis
2012 Standout
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
2015
Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting
2011
Targeting Energy Metabolism in Mycobacterium tuberculosis , a New Paradigm in Antimycobacterial Drug Discovery
2017
Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy
2017
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis
2019 StandoutNobel
Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities
2011
Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!
2018
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
An integrated device for the rapid and sensitive detection of the influenza hemagglutinin
2019 StandoutNobel
Transformation Morphisms and Time-to-Extinction Analysis That Map Therapy Duration From Preclinical Models to Patients With Tuberculosis: Translating From Apples to Oranges
2018
Nutritional Supplementation Increases Rifampin Exposure among Tuberculosis Patients Coinfected with HIV
2014
Fluoroquinolone and Quinazolinedione Activities against Wild-Type and Gyrase Mutant Strains of Mycobacterium smegmatis
2011
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Point-of-Care Diagnostics: Recent Developments in a Connected Age
2016
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
2014 Standout
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis
2019 StandoutNobel
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
2014
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Diagnosing COVID-19: The Disease and Tools for Detection
2020 Standout
Carbofluoresceins and Carborhodamines as Scaffolds for High-Contrast Fluorogenic Probes
2013 StandoutNobel
Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi
2015
The Immune Response in Tuberculosis
2013 Standout
How research can help control tuberculosis.
2009
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
Treatment of Tuberculosis
2015
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Biomedical Importance of Indoles
2013 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
A Fluorogenic Trehalose Probe for Tracking Phagocytosed Mycobacterium tuberculosis
2020 StandoutNobel
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
The Role of Technology in Translational Science
2013
Airborne transmission of respiratory viruses
2021 StandoutScience
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation
2018 StandoutNobel
Works of Roxana Rustomjee being referenced
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project
2012
Phase 1 trial of nonoxynol-9 film among sex workers in South Africa
1999
A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
2014
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
2016
Effect of Standard Tuberculosis Treatment on Plasma Cytokine Levels in Patients with Active Pulmonary Tuberculosis
2012
A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting
2002
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
2010 Standout
Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
2016
The Early Bactericidal Activities of Rifampin and Rifapentine in Pulmonary Tuberculosis
2005
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
2008
Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
2008
Treatment of tuberculosis: present status and future prospects.
2005
Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines
2012
A Semimechanistic Pharmacokinetic-Enzyme Turnover Model for Rifampin Autoinduction in Adult Tuberculosis Patients
2012
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis
2017